LOS ANGELES -- An intervention costing less than a year could save the lives of thousands of HIV-infected children in Africa, researchers said here.
LOS ANGELES, March 1 -- An intervention costing less than a year could save the lives of thousands of HIV-infected children in Africa, researchers said here.
The combination of mosquito bednets treated with insecticide, and daily prophylaxis with co-trimoxazole (Septra, Bactrim), reduced the occurrence of malaria in young HIV patients by 97%, according to Anne Gasasira, M.B., Ch.B., of Makerere University Medical School in Kampala, Uganda.
The combined cost of a bednet and co-trimoxazole for a child under the age of five would be less than a year, Dr. Gasasira said at the Conference on Retroviruses and Opportunistic Infections here.
But widespread use of the intervention "would have a huge effect," she said, "because malaria is still the leading cause of mortality and morbidity in young (African) children."
According to the World Health Organization, malaria causes a million deaths a year, 75% of them in African children under age five. HIV-infected children are highly susceptible to the disease.
Dr. Gasasira conducted a cohort study, comparing 300 HIV-infected children treated at Kampala's Mulago Hospital and 561 healthy children from the community. All were younger than five.
Bednets and co-trimoxazole are each recommended for HIV-infected children, according to study co-author Diane Havlir, M.D., of the University of California at San Francisco, but for different reasons -- the mosquito nets to prevent malaria and the co-trimoxazole to avoid opportunistic infections.
"We were interested in the combination," she said.
The study is similar to one reported in The Lancet in 2004, in which HIV-infected adults were given bednets, antiretroviral therapy, and co-trimoxazole, Dr. Gasasira said. In that study, the researchers found similar but lower benefits for adults than she and colleagues found for children.
The 11-month study began in October 2005, when 88% of the HIV patients were using bednets and all were using co-trimoxazole. At that time, 6% of the healthy children were using bednets and none was taking the medication.
Halfway through the study, any child not reporting the use of a bednet was given one, Dr. Gasasira said, allowing the researchers to stratify the patients into several exposure groups.
The study found:
Compared with the healthy children without bednets and not taking co-trimoxazole, the hazard ratio for the combination among the HIV-infected children was 0.03, with a 95% confidence interval from 0.01 to 0.11. The difference was statistically significant at P
Common Side Effects of Antiretroviral Therapy in HIV Infection
February 7th 2013What are some of the more common side effects of antiretroviral therapy, and what can the primary care physician do to help manage these effects? In this podcast, infectious disease expert Rodger MacArthur, MD, offers insights and points readers to updated comprehensive guidelines.